Prior to parturition the non-pliable uterine cervix undergoes a ripening process ("softens" and dilates) to allow a timely passage of the fetus at term. The exact mechanism(s) triggering and involved in cervical ripening are unknown, though evidence for a role for sensory neurons and their contained neuropeptides is emerging. Moreover, an apparent increase in neuropeptide immunoreactive nerves occurs in the cervix during pregnancy, maternal serum estrogen levels rise at term and uterine cervix-related L6-S1 dorsal root ganglia (DRG) sensory neurons express estrogen receptor (ER) and neuropeptides. Thus, we sought to test the hypothesis that the neuropeptide substance P (SP) changes biosynthesis and release over pregnancy, that estrogen, acting via the ER pathway, increases synthesis of SP in DRG, and that SP is utilized in cervical ripening at late pregnancy. Using immunohistochemistry, in situ hybridization, reverse transcriptase-polymerase chain reaction (RT-PCR) and radioimmunoassay (RIA), we investigated coexpression of ER-G/13 and SP; differential expression of ER-G and -13 mRNA in DRG neurons; SP synthesis in DRG; and changes in SP concentration in the cervix, DRG and spinal cord over pregnancy. In addition, the effect of exogenous estrogen on SP synthesis in L6-S1 DRG of ovariectomized rats was examined. SP-immunoreactive neurons expressed ER-G and ER-13. SP synthesis (expressed as 13-PPT mRNA label) was prominent in small DRG neurons. SP concentration increased in the L6-S1 DRG and spinal cord segments, with a peak at Day 20 of gestation, but decreased in the cervix during the first two trimesters, with a rise over the last trimester to Day 10 levels. SP and ER-G mRNA synthesis increased in DRG over pregnancy but ER-13 mRNA levels were largely unchanged. When ovariectomized rats were treated with exogenous estrogen, SP mRNA synthesis in the DRG increased in a dose-related manner, an effect blocked by ER blocker ICI 182 780. From these results, we postulate that synthesis of SP in L6-S1 DRG and utilization in the cervix increase over pregnancy and this synthesis is under influence of the estrogen-ER system, most likely ER-G. We postulate that SP may play a role in cervical ripening and, consequently in the birth process. 
Introduction
During pregnancy the quiescent uterus provides a favorable environment for the growing fetus and the non-pliable cervix acts as a sphincter to keep the fetus in utero. However, at term the cervix undergoes tissue remodeling leading to softening and dilatation ('ripens'), whereas the uterus contracts to facilitate passage of the fetus. Failure of either or both of these events leads to birthing problems such as preterm birth or protracted labor [13] .
Cervical ripening is a complex process that is regulated by numerous factors, many of which have been studied extensively such as nitric oxide, cytokines, prostaglandins, relaxin and steroids hormones [1, 18, 51, 83] . However, the exact mechanism(s) triggering cervical ripening remain elusive. Moreover, changes in the cervix at ripening are similar to those seen in inflammatory reactions, especially neurogenic inflammation [16, 42] , suggesting that nerves play an important role in cervical ripening. However, even though it is known that the cervix is richly innervated with autonomic and sensory nerves [4, [57] [58] [59] 85] and that transection of the sensory nerves blocks labor [10, 27] , the role of uterine cervix-related nerves is poorly understood.
Our laboratory has established the fundamental anatomic organization essential for neurogenic inflammation in the cervix of parturient rats, which we believe may play a crucial role in cervical ripening [16] . Uterine cervical afferent nerves, containing inflammation-associated neuropeptides, including substance P (SP), are closely associated with leaky venules and smooth muscle cells in the cervix of parturient rats [16] . Interestingly, administration of SP to ovariectomized rats mimics aspects of neurogenic inflammation observed in the parturient cervix, i.e. immune cell recruitment, vasodilation and plasma extravasation, suggesting that SP may play an important role in cervical ripening [16] .
SP is a member of the tachykinin family of peptide neurotransmitters, namely SP, neurokinin A (NKA) and neurokinin B (NKB), that are derived from preprotachykinin (PPT) gene by alternative splicing [12, 53] . Moreover, three distinct G protein-coupled cell membrane receptors, NK1, 2 and 3, are activated preferentially by SP, NKA and NKB, respectively [49, 70] . SP is found in sensory nerves innervating peripheral tissues [28, 55, 71, 72] including the uterine cervix [16, 57, 59, 79] and, when locally released, causes pain and neurogenic inflammation [21, 29] . In addition, NK1 receptor immunoreactivity is associated with target tissues in the cervix and its synthesis increases over pregnancy [16] . However, to date studies are not available on the effects of changing estrogen levels in the cervix over pregnancy, its influence on neurotransmitters and their potential involvement in cervical ripening.
Several studies have established that (i) maternal serum estrogen levels rise over pregnancy peaking near term [8, 46, 76] , (ii) dorsal root ganglion (DRG) neurons express estrogen receptor (ER) [63, 64, 82] including those in the L6-S1 segmental DRG that innervate the uterus [60, 65, 67] , (iii) some ER containing DRG neurons express SP [60, 61] , and (iii) SP is transported to the pelvic organs (cervix included) from L6-S1 DRG [48, 67] . On the basis of these data, we hypothesize that rising estrogen levels at term could stimulate, via ER, an increased synthesis of SP. The neuropeptide is then transported to sensory nerve terminals in the cervix for release and binding to NK1 receptors to participate in remodeling of the cervix.
To test this hypothesis, the present study utilized immunohistochemistry, in situ hybridization, RT-PCR and radioimmunoassay (RIA) to investigate coexpression of ER and SP in DRG neurons, SP synthesis in DRG, and changes in SP concentration in the cervix, DRG and spinal cord over pregnancy. The effect of exogenous estrogen on SP synthesis was investigated in ovariectomized rats.
Materials and methods

Animals
Adult female Sprague-Dawley rats (SASCO strain from Charles Rivers) were used in these studies. Nonpregnant and timed-pregnant rat at gestational days 10, 15, 20, parturient (Day 22) and 2-day postpartum were included in the studies. A total number of 90 pregnant animals [n = 5 (radioimmunoassay, immunohistochemistry and in situ hybridization) and n = 
Radioimmunoassay
Pregnant rats were euthanized with sodium pentobarbital (100 mg/kg body weight, i.p.), and perfused intra-cardially only with 0.9% sodium chloride. The cervix, L6-S1 DRG and spinal cord segments (dorsal one-half only) were carefully removed and stored frozen at −80 • C until processing. Frozen samples were homogenized and extracted in 2 N acetic acid. An aliquot of the homogenate was used for protein determination (Bio-Rad). After centrifugation, the supernatants were lyophilized and used for RIA. SP was determined using antiserum RD2 (gift of Dr. S.E. Leeman), [ 125 I] Bolton-Hunter-SP (Amersham) as radioligand and synthetic SP (Sigma Chemical Co., St. Louis, MO) as standard [40] .
Immunohistochemistry
For immunohistochemical studies of the expression of ER and SP in DRG neurons, nonpregnant rats were ovariectomized. Animals were anesthetized with sodium pentobarbital (45 mg/kg, i.p.) and ovariectomized via two small dorsal incisions. Incisions were closed with a single stitch to the muscle layer and a single wound clip to the skin. After 7-10 days survival the rats were deeply anesthetized (100 mg/kg sodium pentobarbital, i.p.) and exsanguinated by cardiac perfusion with saline followed by 4% para-formaldehyde in 0.1 M phosphate buffer, pH 7.3. The L6-S1 DRG were removed, cryoprotected in 30% sucrose, frozen, and sectioned (14 µm thick) on a cryostat. Sections were processed on slide for immunohistochemistry to localize SP and ER-G or ER-13 by standard techniques routinely used in our laboratory [58, [60] [61] [62] [63] . Briefly, sections of DRG were incubated for 16-24 h at room temperature with a cocktail of primary antibodies: (i) a guinea pig generated antibody against SP (dilution 1:800; gift of Dr. Catia Sternini, CURE at UCLA, Los Angeles, CA) and a rabbit generated antibody against ER-G (1:2500 dilution; code 1355; gift of Dr. Margaret Shupnik, University of Virginia and same antibody purchased from Upstate Biotechnology) or (ii) the SP antibody plus a sheep generated anti-ER-13 antiserum The SP antibody is well characterized [59] . The ER-G antiserum coded C1355 was raised against the last 14 amino acids of the ER and its characterization is established [24] . The ER-13 antiserum was raised in sheep against the N-terminal (code 893/3/34 and 41/P3) and the hinge (code 913/l/36/P4) regions of the ER protein [75] . Controls included omission of the primary antiserum, omission of the secondary antibody, absorption of the primary antiserum with its respective antigen (10 µg/ml of diluted antiserum), and cross-absorption controls.
Tissue sections were viewed with an Olympus Provis Microscope equipped for epifluorescence microscopy (single excitation and emission and dual excitation/emission filters for Alexa488/FITC and CY-3/TRITC). Images were captured with a SPOT TM Digital Camera (Diagnostics Instruments, Sterling Heights, MI), imported into PhotoShop TM V 5.5 (Adobe Systems Inc., San Jose, CA), contrast and brightness adjusted if necessary, labeled and then printed.
In sections immunostained for ER-G+ SP and ER-13 + SP neuron somal profiles were estimated (percentage) to present an idea of relative frequency of subpopulations expressing subtypes of ER and the neuropeptide. Nonadjacent, doublestained sections of L6 and S1 DRG from each of three rats (n = 3) were mounted on separate slides. From each rat nine randomly chosen fields were photographed using a 20× objective and then printed. The number of ER-positive, SP-positive, ER + SP-positive and negative somal profiles in each field were counted from prints and the percentage and standard error were calculated. Only somal profiles with a distinct ER-labeled nucleus or distinct SP-labeled cytoplasm were counted as positive and only profiles with a distinctively unlabeled nucleus or cytoplasm were counted as negative. Profiles in which neither a distinctly labeled nor unlabeled nucleus could be identified, i.e. a profile sectioned through cytoplasm, were omitted from counts.
In situ hybridization (ISH)
In situ hybridization was employed to identify the neurons synthesizing 13-PPT mRNA (and therefore expressing SP) in the L6-S1 DRG during pregnancy and at postpartum. Pregnant animals were euthanized with sodium pentobarbital (100 mg/kg body weight, i.p.) and perfused intra-cardially only with 0.9% sodium chloride. The L6-S1 DRG were then carefully removed and stored frozen at −80 • C until processing.
Preparation of probes
ISH used specific riboprobes. The 13-PPT mRNA plasmid constructs were generated and kindly supplied by Dr. James E. Krause (Neurogen Corp., Bradford, CT). cDNA fragment of 13-PPT was cloned into the multiple cloning site of pG1 (Stratagene# 212205) using restriction enzymes.
The plasmid was linearized with EcoRI and BamHI restriction enzymes, which cut specifically in the polylinker region at the opposite end of the insert from the RNA polymerase promotor that transcribes the cRNA. It was then purified, washed, and concentrated at 200 ng/ml in 1 × TE. Antisense and sense cRNA probes were synthesized using 35 S-UTP (New England Nuclear), purified over a nick column (Pharmacia Biotech, USA) and evaluated on a Bio-Rad 5%-urea ready gel to confirm size of probe and length. Only probes showing a single band in each lane were used for the experiment. Those showing a ladder pattern in each lane were discarded.
Tissue processing and hybridization
Cryostat sections mounted on slides were fixed in 4% para-formaldehyde (pH 9.0), acetylated with 0.25% acetic anhydride in 0.1 triethanolamine (TEA; pH 8.0), washed in 2 × SSC, dehydrated in ethanol series and air-dried before hybridization. Hybridization was performed at 55 • C for 15-18 h. The slides were then washed in the following post-hybridization buffers: thrice 2 × SSC (with DTT), treated with RNase A, washed in 1 × SSC at room temperature (RT), washed thrice in 0.1 × SSC between 63 and 67 • C and dehydrated in ethanol series. The slides were then air-dried and apposed to hyperfilm-13 max, prior to dipping them in Kodak NTB2 nuclear emulsion and exposure.
Estrogen treatment
In order to determine whether estrogen regulates SP synthesis via the classical ER pathway nonpregnant rats were ovariectomized as described above. After 2 weeks, the rats were treated with either increasing doses of 1713-estradiol (Sigma Chemical Co.) (0.03, 0.3, 3.0, 30.0 µg per rat daily for 4 days, s.c., sacrificed 12 h after last injection) or ER antagonist ICI 182 780 (AstraZeneca, Cheshire, UK) (s.c., 4 mg/kg once 12 h prior to 0.3 µg 1713-estradiol, sacri-ficed 12 h later) dissolved in 100 µl of sesame oil. Other ovariectomized animals were treated only with vehicle (100 µl).
Total RNA isolation
Animals (pregnant and ovariectomized rats) were euthanized with sodium pentobarbital (100 mg/kg body weight), IP, and perfused only with 0.9% sodium chloride. The L6-S1 DRG were then carefully removed and stored in the −80 • C freezer until processing. Total RNA was isolated from L6-S1 DRG of individual animals using RNeasy Mini Kit (Qiagen, Valencia, CA). The amount and purity of total RNA for each sample were estimated by spectrophotometric analysis at A260 and A280. The quality of RNA was determined by agarose gel electrophoresis following ethidium bromide staining. Aliquots of total RNA were diluted in diethylpyrocarbonated (DEPC)-treated water and stored at −80 • C.
Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA from DRG and spinal cord was reverse transcribed and amplified in an eppendorf Master Cycler, using reagents from Gene AMP Gold RNA PCR Kit (P.E. Biosystems, Foster City, CA), according to manufacturer's instructions. Briefly, 0.5-1 µg total RNA was reverse transcribed and amplified in a 50 µl reaction mixture containing the following: 5× RT-PCR buffer, 1.75 mM MgCl2, 1.2 mM dNTP's, 10 U RNase inhibitor, 5.0 mM DTT, 1 µM random hexamer, 200 nM SP, ER-G or ER-13 (forpliTaq Gold DNA polymerase, 30 U MultiScribe reverse tocol used for SP (modification of [41] ) was as follows: pre-heated for 10 min at 94 • C followed by 1 min at 94 • C, 1 min at 60 • C, 2 min at 72 • C for 29 cycles and finally 10 min at 72 • C. The RT-PCR protocol used for ER-G and -13 has been described earlier [82] . The sequences used for SP, ER-G and ER-13 were as follows: The RT-PCR reactions were normalized across runs using 18S ribosomal RNA as a standard. A Quantum RNA Kit with 18S primers and competimers for quantitative RT-PCR was used (Ambion, Austin, TX). The ribosomal primers for this kit yielded a 488-bp PCR fragment. The PCR product was separated using agarose gel electrophoresis, visualized after staining with SYBR Green 1 and scanned using the Kodak 1D Image Station (Rochester, NY).
Statistical analysis
RIA and RT-PCR data are shown as means and S.D. (Figs. 1 and 4) . Comparisons among groups were made by ANOVA and t-test. P values less than 0.05 were considered significant. pregnancy (P < 0.0072) (Fig. 1A and B) . The SP concentration in the cervix showed a trend of decreasing between Days 10 and 15 of pregnancy and then a rise thereafter over the last trimester of pregnancy when it returns to Day 10 levels (Fig. 1C) .
Results
3
Immunohistochemistry
Sensory neurons of DRG coexpress SP and ERs
Sections of L6-S1 DRG immunostained for ER-G or ER-13 indicate a subpopulation of neurons immunoreactive for each receptor subtype as well as both ERs (see [62] ). The focus of this study is on neurons that express ER as well as SP immunoreactivity. Sections double immunostained with a cocktail of antibodies against ER-G + SP and ER-13 + SP revealed subpopulations of neurons immunoreactive for ER-G, ER-13, SP, ER-G + SP, and ER-13 + SP (Fig. 2) . About 6.4% of somal profiles estimated were immunoreactive for both ER-G + SP and about 15.1% for ER-13+SP. Though triple immunostaining ganglion sections was not attempted, one should consider, based on previous data [62] that some neurons may express both ER-G + ER-13 + SP.
In situ hybridization
Sensory neurons of DRG express β-PPT mRNA and synthesize SP
In order to confirm a subpopulation of neurons synthesizing and expressing SP in the L6-S1 DRG during pregnancy and at postpartum, ISH for 13-PPT mRNA was performed. 13-PPT mRNA signals were localized in small and medium size neurons of L6-S1 DRG throughout the stages of pregnancy examined (Days 10, 15, 20, parturition) and 2-day postpartum (Fig. 3) . Days 10, 15, 20,  
RT-PCR
SP mRNA in L6-S1 DRG is up-regulated over
parturient (Day 22) of pregnancy and down-regulated by 2-day postpartum
SP mRNA bands showed a noticeable density increase over pregnancy and an apparent decrease by 2-days postpartum (Fig. 4A) . This change became more apparent when the bands were scanned using the Kodak 1D Image Station to produce a histogram of the net intensity of the bands (Fig. 4A, right) . The difference in net intensity of bands at parturient (Day 22) versus Day 10 was statistically significant (P < 0.05).
Exogenous estrogen up-regulates SP mRNA in L6-S1 DRG and this effect can be blocked by ER antagonist ICI 182 780
Ovariectomized rats treated with increasing doses of 1713-estradiol (0.03, 0.3, 3, and 30 µg per rat per day for 4 days) showed a dose-related increase of SP mRNA synthesis in L6-S1 DRG between the ranges of 0.03-3.0 µg (no further response was observed beyond 3.0 µg) (Fig. 4B ). There was a statistical difference between dosages 0.03 and 0.3 µg, and between 0.03 and 3 µg (P < 0.05).
Since exogenous estrogen up-regulates SP mRNA expression and both ER-G and -13 are expressed in neurons of these ganglia [62, 82] , we examined whether the estrogen effects on SP mRNA synthesis were ER-mediated. Administration of the ER antagonist ICI 182 780 to ovariectomized rats 12 h prior to 1713-estradiol, reduces the effects of estrogen (at 3.0 µg) on SP mRNA expression (Fig. 4C) . The partial blockage of SP mRNA synthesis by ER blocker ICI 182 780 was statistically (ICI 182 780) on the short-term treatment effects of estrogen on SP mRNA in DRG of ovariectomized rats. 18S mRNA was used as an internal control. Scanned images of SYB green-stained gels on the left (i) and intensity plotted as a histogram on the right (ii). (A) SP mRNA shows a trend toward up-regulation during pregnancy and decreasing after birth, (B) estrogen administration to ovariectomized rats up-regulates SP mRNA in a dose-related manner with a maximum effect at 3.0 µg, (C) prior administration of ER blocker ICI 182 780 partially prevented the estrogen-induced up-regulation of SP mRNA, (D) ER-G mRNA was up-regulated over pregnancy and decreased after birth, whereas ER-13 mRNA levels (E) remained relatively stable. Note the scale differences for the histograms for ER-G vs. ER-13 mRNA. E: estrogen treatment, ICI + E: estrogen blocker ICI 182 780 + estrogen treatment. (A) * P < 0.05, compared to Day 10; (B) * * P < 0.001, * P < 0.05, compared to 0.03 µg estrogen dosage; (C) * P < 0.01, compared to estrogen treatment; (D) * P < 0.023, compared to Day 10; (E) all days not statistically different; (t-test).
significant compared to the 1713-estradiol-treated animals (P < 0.05). Because ICI 182 780 blocks both subtypes of ER, namely ER-G and -13, we examined whether the expression of both subtypes are in L6-S1 DRG for a clue as to the subtype likely to mediate SP mRNA expression in pregnancy. RT-PCR data revealed that ER-G mRNA tended to increase over pregnancy with a peak at Day 20 of pregnancy (Fig. 4D) . In contrast, ER-13 mRNA levels generally remained stable across pregnancy and were basically unchanged from those expressed in the nonpregnant rat (Fig. 4E) . The difference between Day 20 and Day 10 was statistically significant for ER-G mRNA (P < 0.023), whereas no significant difference was seen between any representative time points in the case of ER-13 mRNA.
Discussion
The important findings of this study are that (1) concentration of SP in L6-S1 DRG rises over the last trimester of pregnancy, but is lower in the cervix during the same period, (2) DRG neurons coexpress ER and SP, (3) SP mRNA in DRG increases over pregnancy and responds in a dose-related manner to estrogen, and (4) ER blocker ICI 182 780 attenuates this estrogen effect. These data suggest that estrogen has a role in up-regulation of SP mRNA and SP synthesis, in part via the ER signaling pathway. These findings are novel in that they strongly implicate interactions between estrogen and the neuropeptide SP in the somata of DRG neurons, their central processes in the spinal cord and peripheral terminals in the uterine cervix.
Moreover, the fundamental components of neurogenic inflammation important for cervical ripening in the cervix of late-pregnant rats, i.e. a network of nerves immunoreactive for inflammation-associated neuropeptides and presence of their receptors closely associated with cervical venules during pregnancy, was established by a previous study [16] . The present findings support the data suggesting that SP is important in changes occurring at cervical ripening and parturition.
Various substances have been studied extensively for their involvement in parturition including cytokines (IL-1, -6, -8 and TNF), oxytocin, prostaglandins and steroid hormones [1, 51, 83] . Interestingly, disruption of individual genes for these substances fails to stop reproductive processes in mice [34] suggesting there is a multiplicity of factors at play in cervical ripening and parturition and possibly some, as yet, undiscovered factors. Along this line, Carlson and De Feo [11] , Higuchi et al. [27] and Burden et al. [10] reported that severing the pelvic nerves enroute to the cervix interferes with, or blocks parturition. This prompted research on factors in the pelvic nerves that are crucial to cervical ripening and parturition.
The cervix is innervated largely by pelvic nerves [4, 5, 58, 65, 66, 85] arising from L6-S1 spinal cord segments, though there are contributions from the vagus [15, 30, 36, 56] and hypogastric nerves [5, 17, 66] . Sensory fibers of the pelvic nerve are most vital for parturition as bilateral dorsal rhizotomy at Days 8-10 of pregnancy produces dystocia whereas bilateral transection of ventral roots does not [10] . Moreover, transection of pelvic and hypogastric nerves blocks reflexive postpartum ovulation that is stimulated by passage of the fetuses through the cervix [17] . The DRG is the major, if not exclusive, source of SP in the cervix [57, 58, 85] and SP is present in small capsaicin-sensitive sensory neurons [69, 85] . Afferent nerves that release transmitters from their central terminals in the spinal cord also perform an efferent function by releasing neuropeptides from their terminals in target tissue [29, 48, 52] . SP, when released from the sensory nerves, produces several effects in peripheral organs [29, 31, 48] including vasodilation, increased permeability of postcapillary venules with plasma extravasation, and recruitment and activation of inflammatory immune cells. These effects are essential features of neurogenic inflammation and are involved in tissue rearrangements [7, 21, 31, 52, 73, 81] . Tissue rearrangements of cervical ripening in preparation for parturition begin at about Day 20 in the rat [16, 18] and resemble those described for neurogenic inflammation [16] . Thus, our data showing increased synthesis of SP in the DRG over pregnancy, with a peak at about Day 20, taken in conjunction with decreasing levels in the cervix, possibly indicating increased release and utilization, support the hypothesis that SP and a local neurogenic inflammatory-type reaction are important components of cervical ripening [16, 42] . It could be argued that increased SP in the DRG with decreased SP in the cervix may result from increased storage versus release. However, the fact that the SP receptor NK1, which is important in pain and inflammatory conditions [68] , is up-regulated in the pregnant cervix maximally at is more consistent with the postulated increased release of SP in the cervix at this time, than increased storage. This data parallels that of estrogen effects on SP-receptor mRNA levels and SP binding in an in vivo and model cell system [9, 22, 89] . Moreover, the slight rise in SP concentration in the cervix of parturient animals may result from the maximized egress of immune cells from the vasculature at this stage, many of which synthesize SP [38] .
In situ hybridization data revealed most intense 13-PPT signal in small neurons with light to moderate signal in medium-size neurons. This may explain why selective antidromic stimulation of C-type axons of (from small DRG neurons) and A-delta (from medium-size neurons) (which induce local neuropeptide release, including SP) have differential effects on pelvic organs. Stimulation of C-fibers (with a higher SP content) causes both vasodilation and neurogenic inflammation, whereas, stimulation at frequencies for A-delta fibers causes only vasodilation [66] . We infer that, based on the collective data above, cervical ripening involves a neurogenic inflammatory-type reaction as an orderly and timely component of cervix remodeling which is vital for passage of the fetus at parturition. In addition, increased SP synthesis in the DRG and transport to, and release in, the cervix at late pregnancy is an important part of this process in the rat. Though SP concentration is lower in the cervix over the last trimester of pregnancy, there was increased concentration of SP in the DRG and dorsal one-half of the spinal cord. The increased concentration of SP in the spinal cord is intriguing, but if it reflects peptide synthesized and transported from the DRG neurons, peptide intrinsic to the spinal cord, SP derived from supraspinal sources or a combination of these is presently unknown. Dorsal rhizotomy and capsaicin-treatment, showed that significant SP content of the L6 spinal dorsal horn is from CNS source(s), though the intrinsic sources were not identified [86] .
Estrogen and progesterone play key roles in establishing the environment leading to successful pregnancy and full-term labor [8, 14, 78, 87] . During the period of progesterone dominance in early pregnancy the cervix is firm and tightly closed. At late pregnancy a sharp rise in estrogen levels changes the estrogen: progesterone balance which favors cervical ripening [78] . This change in hormonal milieu up-regulates factors that enhance uterine contraction and cervical ripening, e.g. oxytocin receptor [25, 26, 39, 88] and immune cells [16, 47] . Moreover, coexistence of ER and SP in sensory neurons of lumbosacral DRG neurons implicates estrogen in the regulation of SP expression and SP involvement in cervical ripening. Furthermore, the temporal coincidence in the rat (at about Day 20) in the rise of serum estrogen (and decline of progesterone) [8, 46, 76] , up-regulation of ER-G mRNA, SP mRNA, and SP in L6-S1 DRG (present study), strongly supports the notion that estrogen, working through ERs, positively influences SP expression.
L6-S1 DRG neurons project axons to pelvic organs other than the uterus and cervix, e.g. the urinary bladder [19, 20, 33, 80] and some of these neurons express ERs [3] . Thus, estrogen could influence the function of the urinary system in addition to the reproductive tract [2, 6, 32, 84] . This influence could occur at the level of the epithelium, smooth muscle, or nerves [3, 23, 50] . Consequently, it is likely that all ER-positive neurons examined in the present study were not necessarily uterus-related. Though, it should be noted that previous studies have not reported a direct effect of steroid hormones on bladder responses to nerve stimulation [74] and micturition thresholds were not altered by estrous cycle stage (i.e. circulating hormone level) in normal rats (but only in bladder inflamed rats) [32] . In any case, this information calls forth an important point, i.e. caution should be exercised when making interpretations about neurons expressing ERs and their role(s) only in reproductive organ circuitries.
Estrogen effects are mediated largely by ER-G and -13 [35, 37] . Small-and medium-size sensory neurons in L6-S1 DRG express one or both ER isoforms [3, 62, 64] . The present study revealed that ER-G mRNA is up-regulated during pregnancy, whereas, ER-13 remains largely unchanged implying that ER-G may play a dominant role during pregnancy and, possibly mediate up-regulation of SP synthesis. 1713-Estradiol stimulated SP mRNA synthesis in ovariectomized rats, an effect blocked by pretreatment with an ER antagonist suggesting that SP synthesis in the DRG during pregnancy may be regulated by the estrogen-ER signaling pathway. Because we do not know if the 13-PPT gene has an estrogen-responsive element (ERE) [54] , it is not clear precisely how estrogen regulates SP. A proposal is that estrogen regulates SP synthesis indirectly by modulating NGF or trkA [43, 77] , which express EREs, and these regulate SP [43] [44] [45] . ICI 182 780, may, therefore, block SP up-regulation by preventing binding of the estrogen-ER complex to the ERE of NGF.
Taking the present data in concert with the current literature we propose one avenue by which estrogen may influence initiation of cervical ripening. Estrogen could enhance the sensitivity of nerves at the internal of the cervix to fetal mechanical stimuli and up-regulate synthesis of SP and NK1 in DRG and cervix, respectively with concomitant enhanced release of SP in the cervix. SP, in concert with other inflammation-associated neuropeptides, promotes a neurogenic inflammatory-type response and tissue rearrangements. Thus, SP, in part, under the influence of estrogen-ER-G, may help establish conditions critical for cervical ripening in preparation for parturition.
